Skip to content

Total Equity at other companies

AbbVie logo
AbbVieABBV
-$6.66B-569%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-$34.05M+44.1%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$1.25B+63.1%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$562.3M+34.3%
uniQure logo
uniQureQURE
$149.34M+343%
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's total equity?
Alpha Cognition (ACOG) reported total equity of $57.46M in Q1 2026.
How has Alpha Cognition's total equity changed year-over-year?
Alpha Cognition's total equity increased by 49.2% year-over-year, from $38.5M to $57.46M.
What is the long-term trend for Alpha Cognition's total equity?
Over 3 years (2022 to 2025), Alpha Cognition's total equity has grown at a 261.8% compound annual growth rate (CAGR), from -$1.32M to $62.53M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.